Nektar Therapeutics logo

Nektar Therapeutics

LTS:0UNL (USA)   Ordinary Shares
$ 1.81 (+1.4%) May 16
At Loss
P/B:
2.65
Market Cap:
$ 336.03M
Enterprise V:
$ 160.87M
Volume:
4.33K
Avg Vol (2M):
23.96K
Also Trade In:
Volume:
4.33K
At Loss
Avg Vol (2M):
23.96K

Nektar Therapeutics Valuation Measures